These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8093908)

  • 1. Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1.
    Ohshima E; Takami H; Harakawa H; Sato H; Obase H; Miki I; Ishii A; Ishii H; Sasaki Y; Ohmori K
    J Med Chem; 1993 Feb; 36(3):417-20. PubMed ID: 8093908
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.
    Ohshima E; Otaki S; Sato H; Kumazawa T; Obase H; Ishii A; Ishii H; Ohmori K; Hirayama N
    J Med Chem; 1992 May; 35(11):2074-84. PubMed ID: 1350797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic optical resolution of dibenzoxepins and its application to an optically active antiallergic agent with thromboxane A2 receptor antagonistic activity.
    Kuge Y; Shioga K; Sugaya T; Tomioka S
    Biosci Biotechnol Biochem; 1993 Jul; 57(7):1157-60. PubMed ID: 7763987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2/prostaglandin H2 receptor antagonists.
    Le Breton GC; Lim CT; Vaidya CM; Venton DL
    Methods Enzymol; 1990; 187():406-14. PubMed ID: 2146463
    [No Abstract]   [Full Text] [Related]  

  • 5. Dibenzoxepin derivatives: thromboxane A2 synthase inhibition and thromboxane A2 receptor antagonism combined in one molecule.
    Ohshima E; Sato H; Obase H; Miki I; Ishii A; Kawakage M; Shirakura S; Karasawa A; Kubo K
    J Med Chem; 1993 May; 36(11):1613-8. PubMed ID: 8496929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
    Miki I; Nonaka H; Ishii A
    Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and optical resolution of an antiallergic agent KW4099 with thromboxane A2 antagonistic activity.
    Sugaya T; Kuge Y; Tomioka S; Tamaki K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):238-9. PubMed ID: 1576677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
    Miki I; Ishii A
    Thromb Haemost; 1992 May; 67(5):582-4. PubMed ID: 1387741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of antiallergic agents. I. Synthesis and activity of 11-(2-aminoethyl)thio-6,11-dihydrodibenz[b,e]oxepin derivatives.
    Ohshima E; Kumazawa T; Takizawa H; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2724-8. PubMed ID: 1687210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists.
    Hall SE; Han WC; Harris DN; Hedberg A; Ogletree ML
    J Med Chem; 1989 May; 32(5):974-84. PubMed ID: 2523485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new series of antiallergic agents. II. Synthesis and activity of new 6,11-dihydrodibenz[b,e]oxepin-carboxylic acid derivatives.
    Kumazawa T; Ohshima E; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2729-33. PubMed ID: 1687211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.
    Ohshima E; Takami H; Sato H; Obase H; Miki I; Ishii A; Karasawa A; Kubo K
    J Med Chem; 1992 Sep; 35(18):3394-402. PubMed ID: 1388207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of histamine H1- and H2-receptors in the generation of thromboxane A2 in perfused guinea-pig lungs.
    Berti F; Folco GC; Nicosia S; Omini C; Pasargiklian R
    Br J Pharmacol; 1979 Apr; 65(4):629-33. PubMed ID: 435687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 does not play a role in the development or maintenance of hypertension in spontaneously hypertensive rats.
    Stegmeier K; Sponer G; Pill J
    Prog Clin Biol Res; 1987; 242():253-7. PubMed ID: 2959964
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 17. Azulene derivatives: new non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Wakabayashi S; Kosakai K; Yokota M
    J Med Chem; 1990 Sep; 33(9):2323-6. PubMed ID: 2144025
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig.
    Underwood DC; Muccitelli RM; Luttmann MA; Hay DW; Torphy TJ; Wasserman MA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):304-10. PubMed ID: 8301572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.